Peter Kirwan

About

I’m a Research Associate at the MRC Biostatistics Unit in Cambridge. My PhD focussed on applications of multi-state models to estimate infectious disease burden, specifically HIV and COVID-19. My current research involves the development of multi-state "back-calculation" models to estimate HIV incidence and undiagnosed HIV prevalence.

GitHub ยท ORCiD ยท Mastodon

Peter Kirwan

Statistical methods for survival data

This series of blog posts provides an introduction to statistical methods for survival data, with applications for infectious disease modelling and epidemiology. Topics include: classical survival methods, competing risks analysis, and causal inference from observational data.

Part II: Survival analysis

An introduction to survival analysis, time-to-event data, and how we handle censored observations in epidemiological research.

Censoring Truncation Hazard function Survival function
Survival analysis

Part III: Classical survival methods

Exploring two fundamental approaches to analysing survival data: non-parametric Kaplan-Meier estimation and semi-parametric Cox proportional hazards models.

Likelihood Survival models Kaplan-Meier Cox models
Survival analysis

Recent publications

๐Ÿ“ƒ Protection of vaccine boosters and prior infection against mild/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024. View article โ†’

๐Ÿ“ƒ Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort. View article โ†’

๐Ÿ“ƒ Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing. View article โ†’

๐Ÿ“ƒ Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study. View article โ†’

For a full list of publications, see my Google Scholar or ORCiD page.

Contact

Feel free to reach out about research collaborations, speaking opportunities, or general enquiries: